Lansomac 30 is made in the form of hard capsules, the main ingredient is Lansoprazole. The drug is used in the treatment of esophagitis, peptic ulcer...

Lancap - 30 is indicated in the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease, treatment of Zollinger - Ellison syndrome. So what are the notes when using Lancap - 30?

Lansolek contains the main active ingredient Lansoprazole with a content of 30mg of Lansoprazole microgranules that are coated in the intestine. The dosage form of the drug is a hard capsule containing Lansoprazole microgranules that are coated in the intestine, suitable for direct oral use. The packaging is a box of 10 blisters and each blister contains 10 hard capsules. Lansolek belongs to the group of drugs that treat diseases of the digestive tract.

Langamax medicine has the main active ingredient Lansoprazole with a content of 30mg of Lansoprazole microgranules that are coated in the intestine. Which dosage form is suitable for direct oral use? The packaging is a box of 3 blisters, each blister containing 10 hard capsules. Langamax medicine belongs to the group of drugs that treat diseases of the digestive tract.

Lanlife medicine has the main active ingredient Lansoprazole with a content of 30mg and other excipients in sufficient quantities. The dosage form of the medicine is capsules, suitable for direct oral use. The packaging is a box of 3 blisters and each blister contains 10 hard capsules. Lanlife medicine belongs to the group of drugs for treating diseases of the digestive tract.

Lanprasol medicine has the main active ingredient Lansoprazole with a content of 30mg and other excipients in sufficient quantities. The dosage form of the medicine is capsules, suitable for direct oral use. Lanprasol medicine belongs to the group of drugs that treat diseases of the digestive tract such as esophagitis with ulcers, acute gastric-duodenal ulcers, and Zollinger-Ellison syndrome.

Lezovar contains the main active ingredient Lansoprazole with a content of 15mg and other excipients in sufficient quantities. The dosage form of the drug is capsules, suitable for direct oral use. Lezovar belongs to the group of drugs that treat gastrointestinal diseases such as acute gastric-duodenal ulcers, erosive esophagitis, and Zollinger-Ellison syndrome.

Labapraz is a gastric acid secretion inhibitor and proton pump inhibitor, with the main active ingredient Lansoprazole in the form of slow-release capsules. Labapraz is effective in the treatment of acute gastric and duodenal ulcers and a number of other diseases.